This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Elaine Tuong Vo: Innovator in Stem Cell Research
Introduction
Elaine Tuong Vo is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of stem cell research, particularly in the differentiation of human pluripotent stem cells into smooth muscle-like cells. Her innovative work has the potential to advance medical treatments and regenerative therapies.
Latest Patents
Elaine Tuong Vo holds 1 patent for her invention titled "Smooth muscle-like cells (SMLCs) derived from human pluripotent stem cells." This invention outlines a method for differentiating mammalian pluripotent stem cells into smooth muscle-like cells in vitro. The process involves several steps, including plating a single-cell suspension of pluripotent stem cells, culturing them under specific conditions, and using growth factors to induce differentiation. The method aims to enhance the maturation and functionality of the cells, which could have significant implications for vascular biology and regenerative medicine.
Career Highlights
Elaine is affiliated with The Johns Hopkins University, where she conducts her research and contributes to the academic community. Her work is recognized for its innovative approach to stem cell differentiation, which is crucial for developing new therapies for various medical conditions.
Collaborations
Elaine has collaborated with notable colleagues, including Sharon Gerecht and Donny Hanjaya-Putra. These collaborations have further enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Elaine Tuong Vo is a trailblazer in the field of stem cell research, with her innovative patent paving the way for future advancements in medical science. Her contributions are vital for the ongoing exploration of regenerative therapies and their applications in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
